Background and aim of the study: The diagnostic yield of small-bowel capsule endoscopy (SBCE) in suspected small bowel bleeding (SSBB) is highly variable. Different reimbursement systems and equipment costs also limit SBCE use in clinical practice. Thus, minimising non-diagnostic procedures is advisable. This study aims to assess the SBCE diagnostic yield and identify factors predicting diagnostic findings in a cohort of SSBB patients.
Materials and methods: In this retrospective cohort study, we analysed the medical records of patients who consecutively underwent SBCE for SSBB over nine years. By logistic regression, we identified covariates predicting diagnostic findings at SBCE. Finally, we performed a post-hoc cost analysis based on previous gastroenterologist or endoscopist (G/E) consultations versus direct SBCE ordering by other specialists (OS).
Results: The final analysis included 584 patients. Most SBCEs were ordered by G/E (74%). The number of SBCEs without any finding was significantly lower in the G/E group (p<0.001). The SBCE diagnostic yield ordered by G/E was significantly higher than that by OS (63% vs 52%, OR 1.57; 95%CI: 1.07-2.26, p=0.019). At multivariate analysis, older age (OR 1.7, 95%CI 1.2-2.4, p=0.005), anaemia (OR 4.9, 95%CI 1.9-12, p=0.001), small bowel transit time (OR 1, 95%CI 1-1.02, p=0.039), and referring physician (OR 1.8, 95%CI 1.1-2.7, p=0.003), independently predicted diagnostic findings. Implementing prior G/E referral vs direct SBCE ordering would reduce medical expenditures by 16%.
Conclusions: The professional background of referring physicians significantly improves the diagnostic yield of SBCE and contributes to controlling public health costs.